Clinical

Dataset Information

0

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers


ABSTRACT: The purpose of this study was to assess the safety, tolerability, and efficacy when combining MK-3475 and INCB024360 in participants with certain cancers. This study was conducted in 2 phases, Phase 1 and Phase 2.

DISEASE(S): Endometrial Cancer,Microsatellite Instability,Carcinoma,Lung Cancer,Triple Negative Breast Neoplasms,Hepatocellular Carcinoma (hcc),Triple Negative Breast Cancer (tnbc),Melanoma,Microsatellite-instability (msi) High Colorectal Cancer (crc),Bladder Cancer,Endometrial Neoplasms,Lymphoma,Uc (urothelial Cancer),Renal Cell Carcinoma (rcc),Ovarian Cancer,Gastric Cancer,Carcinoma, Renal Cell,Head And Neck Cancer,Solid Tumors

PROVIDER: 2169682 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2182574 | ecrin-mdr-crc
| 2176584 | ecrin-mdr-crc
| 2268996 | ecrin-mdr-crc
| 2204103 | ecrin-mdr-crc
| 2281087 | ecrin-mdr-crc
| 2293836 | ecrin-mdr-crc
| 2195231 | ecrin-mdr-crc
| 2230469 | ecrin-mdr-crc
2003-02-27 | GSE318 | GEO
2003-02-27 | GSE317 | GEO